In all, these data demonstrate a novel MSI2-translocation driven downstream event that leads to a more energetic, differentiation arrested aggressive state thus triggering CML progression to bcCML. The gene discussed is MSI2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.